Skip to main content
  • MitraClip 30-Day Readmissions and Impact of Early Discharge: An Analysis from the Nationwide Readmissions Database 2016

    Highlights

    • The overall 30-day MitraClip readmission rate is 13.5%.
    • Readmission rate among patients discharged early (<48 h) is 10.1%.
    • Early discharge (<48 h) post-MitraClip treatment is feasible and safe.
    • Special considerations for postprocedural complications and heart failure patients.

    Abstract

    Background/Purpose

    Edge-to-edge mitral valve repair (MVR) using the MitraClip (Abbott Vascular, Santa Clara, CA), is now labeled for patients with degenerative and functional mitral regurgitation. Because this is a minimally invasive transcatheter procedure, patients are commonly discharged early post-procedure, yet rates and causes of early readmissions are unknown. This study aimed to evaluate underlying causes and trends of 30-day readmissions using the 2016 US Nationwide Readmissions Database (NRD) in patients discharged early after MVR with MitraClip.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details